Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)

August 2, 2012

Pharmaceutical Technology

The authors compare direct combustion with rinse and swab sampling methods.

Measuring Growth in Big Pharma's Manufacturing Investment

August 2, 2012

Pharmaceutical Technology

Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.

Pharmaceutical-Based Cargo Security and Theft Prevention

August 2, 2012

Pharmaceutical Technology

The author discusses strategies for preventing cargo theft.

Drug Delivery Insights: Nanotechnology and Microspheres

August 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments.

Medicines Top EU's Counterfeit List

July 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European Union customs in 2011.

AstraZeneca Restructures Vaccines R&D and Operations

July 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

MedImmune, the global biologics arm of AstraZeneca, announced that it is restructuring its infectious disease and vaccines R&D and operations. This will result in the closure of MedImmune's sites in Mountain View and Santa Clara, California.

Sandoz Completes Acquisition of Generic Dermatology Company Fougera for $1.5 billion

July 23, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Sandoz announced it has completed the acquisition of Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.5 billion.

A Look into the Future: The Pharmaceutical Company of 2020

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.

Biosimilars: Market Weaknesses and Strengths

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here